Interleukin-13 receptor subunit alpha-2 (IL-13Rα2), also called CD213A2, CT19, IL-13R, IL13BP, is a membrane bound protein that in humans is encoded by the IL13RA2 gene. This protein is a component of the cell surface receptor. Compared to IL-13Rα1, IL-13Rα2 play an opposite role as a potent IL13 antagonist. IL-13Rα2 is infected in the disease of glioblastoma multiforme and malignant glioma though the pathway of immune system and Akt signaling.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy product with the complete TCR complex without HLA matching dependence.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE